Drug-induced noncardiogenic pulmonary edema occurred in a previously healthy patient receiving dextran 40. Dextran 40 should be considered another etiologic factor of drug-induced noncardiogenic pulmonary edema when this syndrome occurs in the absence of known precipitating causes such as shock, aspiration, and overwhelming pneumonia.
D
rug-induced noncardiogenic pulmonary edema has I)c.cn reported in association with heroin,' methatlo~~e,"ropoxypl~e~~e,:' and salicylates in excess dosage.' Our experience with l~ilateral diffuse lung infiltrates, severe hypoxemia, decreased lung compliance requiring volume cycled respiration and positive endexpiratory pressure associated with dextran 4 0 (Rhromacrodex) has led us to conclude that this drug is allother agent capal~le of producing drug-induced noncardioge~lic pulmonary edema that might lead to the adult respiratory distress syndrome.
A Itealthy, nonallergic, 220 pound, 30-year-old fireman fell frottt a ntotorl>ike, sustaining minor soft tissue injuries of both lo\vrr c.xtrt.tnitic.s. Ko fractures occurred, and the patient did not lose consciottsness. On admission, his legs were tender, I B I I~ 1111 definite pItIc*l)itis \vas present. The lungs were clear to pc~rcttssion anti artscl~ltation. An x-ray film of the chest was clc.;tr. Artcriitl I)lood gas analysis \\.as not perfomled. Routine I;~l)or;ttory work including complete blood count, chemistry profile, arltl llrinalysis \*'ere \\tithin nonnal limits. Despite ncg;~tivr \vsnogratns of the lower extremities, heparin, and sltl)st.cluc~ntly dextr;ln 40 (Rheomacrodex) 2000 mg per day, \vcBrc. ;~tlt~tinistered intravenously for suspected phlebitis in s\vollen ;untI painfttl legs. Four days after the initiation of tlcstriln 40, the patient I~ecame tachypneic and dyspneic. Pc.techiae \vcBre ahsent. Ar~scrtltation of the lungs revealed cliffuse rliles I>ilaterally. Arterial blood gas analysis with the patient 1)re;ltlting atnl>ient air revealed pH 7.47, Po:! 33, Pco:! 34. There were no significant changes in the complete blood count or chetnistry profile. The urine was free of fat. Diffuse nlvc-olar infiltrates without cardiotnegaly were noted on chest x-ray esatttin;~tion ( Fig 1A) . After failure to oxygenate the patient adecjllately with an inspired oxygen concentration of 80 percent atltninistered via a rebreathing mask, the patient \v;ts intrll>ated and placed on a volume-cycled respirator (Etnersot~) at 8 ctn H -0 positive end-expiratory pressure. Heparin ant1 dextran 40 were withheld. Adequate oxygenation \\,as achieved \\it11 inspired oxygen concentrations of 50 percent ;tt 8 90, Pco:! 37. The chest x-ray film showed complete clearing (Fig 1B) .
Although hemodynamic measurements such as central venous pressure and pulmonary wedge pressures were not determined, it is unlikely that the pulmonary edema pattern noted on the x-ray film was cardiogenic in nature in view of the absence of abnormal auscultatory findings, electrocardiographic or enzyme changes. Inspection of the patient's intake and output ruled out fluid overload as a possible cause of the bilateral alveolar infiltrates. Data and Nies,qn their recent extensive review, noted that dextran 40 does cause plasma expansion that can FIGURE 1B. Return of chest x-ray film to nom~al 12 days after dextran 40 was discontinued.
precipitate congestive heart failure in borderline situations. It is unlikely that this was the cause of the pulmonary edema in \view of the excellent cardiac status of this man. At no time in the patient's hospital course were any of the well-known conditions associated with the picture of edema of the adult respiratory distress syndrome such as shock, aspiration, ovenvhelming pneumonia, pulmonary embolism, hemorrhage, or hypoxemia detected prior to the onset of the tachypnea and d y~p n e a .~ Additionally, none of the compounds associated with druginduced noncardiogenic ~u l m o n a r y edema such as heroin,' methadone,' p r~p o x y p h e n e ,~ or salicylates4 were administered to this patient.
It is uncertain which mechanism leads dextran 40 and other drugs to produce capillary leakage in the lungs which manifests itself as noncardiogenic pulmonary edema. Such pulmonary capillary leakage and subsequent pulmonary edema were not included among the adverse reactions to dextran 40 noted by Data and Nies.j Sensitivity to the dextran polymer itself or to possible bacterial contaminants in commercial dextran have been associated with various allergic reactions including anaphylaxis.' It is unlikely that the allergic mechanism was operative, as this was the patient's first apparent exposure to dextran 40. Bailey and colleagues' have reported that subtle exposure to dextran, such as might occur with contamination of commercial sugar, could serve as a potential source of sensitization in patients who later react to dextran. \Vhether or not such previous sensitization occurred in our patient cannot be determined. Anaphylaxis is ruled out as the cause of the pulmonary edema because of the four-day period between the initial dose of dextran 40 and the development of tachypnea and dyspnea. It is most likely that the drug had a direct toxic effect upon the pulmonary capillaries similar to that described for the pulmonary edema seen with methadone. ' Heparin potentiates the effect of dextran 40.g It is recommended that the dosage of dextran 40 b e lowered when it is administered concomitantly with heparin. There was no readjustment of the dextran 40 dose in our case. It is conceivable that heparin potentiated the dextran 40 and facilitated the chain of events that caused the alveolar capillary leakage.
In view of the absence of any of the usual etiologies associated with drug-induced noncardiogenic pulmonary edema, this patient demonstrates that dextran 40 should be considered a possible etiologic factor when pulmonary edema and the syndrome of adult respiratory distress occur when this drug is being administered.
